Vyndamax 61 MG capsule UD 30S
Ended Awarded
- Contract number
- SPE2DB25FE3L5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,847
Award facts
- Contract value 100% obligated
- $13,846.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,846.97 to AmerisourceBergen Drug Corp for VYNDAMAX 61 mg capsules (30-count unit dose) on August 28, 2025, with completion targeted for September 19, 2025. This firm fixed-price, competitively awarded delivery order—issued without set-aside designation—represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania.
This delivery order exemplifies AmerisourceBergen's role as a critical pharmaceutical supplier to federal military and veteran healthcare systems through the DLA's medical supply chain. As a major pharmaceutical distributor, AmerisourceBergen fulfills orders across a comprehensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities supporting military medical programs worldwide. The SPE2DX IDC serves as a flexible vehicle enabling consistent pharmaceutical procurement for the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities, with DLA planning to establish the next-generation Pharmaceutical Prime Vendor Global Program (Generation V) with multiple regional awards.
Quick answers
Who was awarded contract SPE2DB25FE3L5?
SPE2DB25FE3L5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 28, 2025.
How much is contract SPE2DB25FE3L5 worth?
The government has obligated $13,847 on SPE2DB25FE3L5.
Is contract SPE2DB25FE3L5 an order under another contract?
Yes. SPE2DB25FE3L5 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FE3L5 competed?
The extent of competition for SPE2DB25FE3L5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award